Back to Search

LAURA GUAY, MD

MD

Pediatric Infectious Diseases Physician

NPI: 1306988837Individual

Specialties, Licenses & Credentials

Pediatric Infectious Diseases PhysicianPrimary

Pediatrics — Pediatric Infectious Diseases

Code: 2080P0208X

D0051133(MD)

Research & Publications (20)

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
PMID 12131216·AIDS·2002
3-trial
From research to implementation: challenges in the prevention of mother to child HIV transmission in the developing world.
PMID 11378518·Trends Mol Med·2001
8-other
HIV-1 ICD p24 antigen detection in ugandan infants: use in early diagnosis of infection and as a marker of disease progression.
PMID 11074470·J Med Virol·2000
8-other
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
PMID 19621988·AIDS Res Hum Retroviruses·2009
4-observational
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
PMID 19552593·AIDS Res Hum Retroviruses·2009
8-other
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
PMID 19617849·J Acquir Immune Defic Syndr·2009
2-rct
Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs.
PMID 19593079·AIDS·2009
8-other
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
PMID 19397436·AIDS Educ Prev·2009
8-other
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
PMID 18684096·J Infect Dis·2008
8-other
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
PMID 18657709·Lancet·2008
8-other
Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
PMID 18845960·J Acquir Immune Defic Syndr·2008
8-other
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
PMID 18769352·J Acquir Immune Defic Syndr·2008
8-other
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
PMID 18788912·AIDS Res Hum Retroviruses·2008
8-other
HIV-1 tropism and survival in vertically infected Ugandan infants.
PMID 18444795·J Infect Dis·2008
3-trial
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
PMID 17262714·J Infect Dis·2007
3-trial
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
PMID 17507467·J Virol·2007
8-other
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
PMID 17604538·AIDS Res Hum Retroviruses·2007
3-trial
Field theoretic description of the Abelian and non-Abelian Josephson effect.
PMID 17677954·Phys Rev Lett·2007
8-other
The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.
PMID 17786129·J Acquir Immune Defic Syndr·2007
3-trial
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
PMID 17885298·AIDS·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
600 N WOLFE ST, CARNEGIE 443
BALTIMORE, MD 21287

Location

Practice Location

600 N WOLFE ST, BALTIMORE, MD
(410) 502-3011

Quick Facts

NPI
1306988837
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile